Physician

Edward H. Kaplan, M.D.

According to 2025 Medicare claims, Edward Kaplan, M.D. (NPI: 1639181084) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is CITY OF HOPE MEDICAL GROUP OF ILLINOIS PLLC (NPI: 1548258072; TIN: 364306053) and primary practice location at 60053-1312.

Kaplan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 665 traditional Medicare patients, billed 138,139 HCPCS/CPT codes, and received $3,251,544 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 943 prescription claims across 152 beneficiaries totaling $3,385,945 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 48 claims. Open Payments data shows 279 records totaling $7,419. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,369,870 to $3,251,544. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,062,754 to $3,385,945. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.9M2015 Medicare payment: $2,369,870 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,168,372 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,418,040 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,259,687 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,180,457 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,067,720 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,621,896 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,057,049 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,881,595 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,251,544 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015454124,247$2,369,870
2016428100,685$2,168,372
2017437133,939$2,418,040
2018425130,500$2,259,687
2019412135,347$2,180,457
2020371144,427$3,067,720
2021412206,475$3,621,896
2022423167,612$4,057,049
2023456168,866$4,881,595
2024665138,139$3,251,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$3.9M2015 Drug cost: $2,062,754 (USD; Tot_Drug_Cst)2016 Drug cost: $1,883,154 (USD; Tot_Drug_Cst)2017 Drug cost: $2,409,786 (USD; Tot_Drug_Cst)2018 Drug cost: $1,790,137 (USD; Tot_Drug_Cst)2019 Drug cost: $1,758,331 (USD; Tot_Drug_Cst)2020 Drug cost: $2,657,899 (USD; Tot_Drug_Cst)2021 Drug cost: $3,437,541 (USD; Tot_Drug_Cst)2022 Drug cost: $3,907,024 (USD; Tot_Drug_Cst)2023 Drug cost: $3,685,740 (USD; Tot_Drug_Cst)2024 Drug cost: $3,385,945 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151631,486$2,062,754
20161491,238$1,883,154
20171541,268$2,409,786
2018157967$1,790,137
2019147940$1,758,331
20201471,045$2,657,899
20211531,102$3,437,541
20221501,139$3,907,024
2023152983$3,685,740
2024152943$3,385,945

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$31K2016 Medicare payment: $31,293 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $29,700 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,835 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $2,370 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,040 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,777 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $8,408 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,280 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R80$31,293
2017N/R86$29,700
2018N/RN/RN/R
2019N/R25$2,835
2020N/R25$2,370
2021N/R28$2,040
2022N/R51$1,777
2023N/R57$8,408
2024N/R48$1,280

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more180315$145
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more283592$103
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more133172$67
36415Insertion of needle into vein for collection of blood sample5151,612$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4431,718$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide23644$513,424
ImbruvicaIbrutinib33964$500,175
TagrissoOsimertinib Mesylate18540$303,076
CalquenceAcalabrutinib Maleate23690$270,192
InlytaAxitinib11330$227,154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8700Temozolomide, oral, 5 mgNN/R12$562
J8521Capecitabine, oral, 500 mgNN/R14$455
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R22$263

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.277$5,092AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.2$2,327GlaxoSmithKline, LLC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Edward H. Kaplan, M.D.?

Tedicare shows public-source Medicare data for Edward H. Kaplan, M.D. (NPI 1639181084), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward H. Kaplan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward H. Kaplan, M.D.?

Edward H. Kaplan, M.D. is linked to CITY OF HOPE MEDICAL GROUP OF ILLINOIS PLLC (billing NPI 1548258072) in the available physician profile data.

Does Edward H. Kaplan, M.D. have Open Payments data?

Edward H. Kaplan, M.D. has 279 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.